Market revenue in 2023 | USD 798.3 million |
Market revenue in 2030 | USD 1,176.1 million |
Growth rate | 5.7% (CAGR from 2023 to 2030) |
Largest segment | Crohn's disease |
Fastest growing segment | Ulcerative Colitis |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Crohn's Disease, Ulcerative Colitis |
Key market players worldwide | AbbVie Inc, Takeda Pharmaceutical Co Ltd, Pfizer Inc, Biogen Inc, Novartis AG ADR, Eli Lilly and Co, UCB SA, Merck & Co Inc, Johnson & Johnson, Celltrion Healthcare |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to inflammatory bowel disease treatment market will help companies and investors design strategic landscapes.
Crohn's disease was the largest segment with a revenue share of 56.5% in 2023. Horizon Databook has segmented the Latin America inflammatory bowel disease treatment market based on crohn's disease, ulcerative colitis covering the revenue growth of each sub-segment from 2018 to 2030.
According to an observational study published by the National Library of Medicine in 2017, the incidence rate of Crohn’s disease ranged from 0.24 to 3.5 per 100,000 individuals, whereas the incidence rate of ulcerative colitis ranged from 0.74 to 6.76 per 100,000 individuals in the region.
The Latin America inflammatory bowel disease treatment market is expected to grow at a lucrative rate over the forecast period. Furthermore, rising demand for advanced treatment strategies is expected to drive the market in Latin America.
Increasing private-public partnerships to promote research on novel drug development, along with rising R&D activities and funding for research, are likely to propel the market in this region during the forecast period.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America inflammatory bowel disease treatment market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America inflammatory bowel disease treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account